Publications by authors named "H Vernaeve"

Claim this Profile
T
TERT promoter mutations are useful to distinguish phyllodes tumours with a fibroadenoma-like morphology from cellular fibroadenomas.
Alex Fortun, Hilde Vernaeve, Anne-France Dekairelle, Ophélie Simon, Tanja Schraepen

Histopathology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of Equivocal HER2 In Situ Hybridization Groups 3 and 4, and Comparison With HER2 mRNA Expression: The Thin Line Between Amplified and Nonamplified Breast Cancers.
Ximena Baez-Navarro, Julia Riggi, David Zylberberg, Angelique van der Made, Dominique Dubois, Hilde Vernaeve

Arch Pathol Lab Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk perception of patients with ductal carcinoma (DCIS) of the breast and their healthcare practitioners: The importance of histopathological terminology, and the gaps in our knowledge.
Julia Riggi, Christine Galant, Hilde Vernaeve, Maud Vassilieff, Martine Berlière

Histol Histopathol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas.
Mieke R Van Bockstal, Marie-Caroline Depelsemaeker, Lina Daoud, Quitterie Fontanges, Aline Francois, Hilde Vernaeve

Pathol Res Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma.
Mieke R Van Bockstal, Hélène Dano, Naima Benhaddi, Dominique Dubois, Jonathan Vanderveken, Hilde Vernaeve

Histol Histopathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis